Production and use of IL-6
US6348191B1 · kind B1 · utility
3Cited by
4References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 1991 |
| Grant date | Feb 19, 2002 |
| Priority date | — |
| Expiry date | Jun 17, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/395
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
IL-6 is produced via recombinant DNA techniques. The peptide is useful in the treatment of disorders characterized by deficiencies in hematopoietic cells and in combination with other hematopoietins in cancer therapies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.